CN106729212A - Treat compound traditional Chinese medicine composite and its application of acute stage of gout - Google Patents
Treat compound traditional Chinese medicine composite and its application of acute stage of gout Download PDFInfo
- Publication number
- CN106729212A CN106729212A CN201710022330.4A CN201710022330A CN106729212A CN 106729212 A CN106729212 A CN 106729212A CN 201710022330 A CN201710022330 A CN 201710022330A CN 106729212 A CN106729212 A CN 106729212A
- Authority
- CN
- China
- Prior art keywords
- parts
- gout
- acute stage
- chinese medicine
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/90—Smilacaceae (Catbrier family), e.g. greenbrier or sarsaparilla
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/21—Amaranthaceae (Amaranth family), e.g. pigweed, rockwort or globe amaranth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
- A61K36/284—Atractylodes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/481—Astragalus (milkvetch)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/69—Polygalaceae (Milkwort family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/756—Phellodendron, e.g. corktree
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/894—Dioscoreaceae (Yam family)
- A61K36/8945—Dioscorea, e.g. yam, Chinese yam or water yam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/898—Orchidaceae (Orchid family)
- A61K36/8984—Dendrobium
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a kind of compound traditional Chinese medicine composite for treating acute stage of gout, raw material includes the Radix Astragali, honey-fried RADIX POLYGALAE, the stem of noble dendrobium, radix achyranthis bidentatae, honeysuckle, rhizoma atractylodis, golden cypress, Bi Collettiis, smilax, corydalis tuber by weight, the Radix Astragali is reused in side, building up healthful vital energy is commanding the through disease institute of all medicines, eliminating evil is gone out, and it is monarch drug in a prescription to exempt from numbness and remove stagnant；Stem of noble dendrobium slightly sweet flavor, property is trembled with fear partially, and nourishing Yin and promoting production of body fluid heat-clearing is with principal drug assistance；Smilax, golden cypress are cold in nature to win heat, and hardship is apt to remove the damp and hot of lower Jiao with eliminating dampness；Bi Collettii, rhizoma atractylodis invigorating the spleen to dry eliminating impediment, are altogether ministerial drug；Honeysuckle removing toxicity for detumescence, corydalis tuber blood stasis dispersing and deswelling, the common swelling and pain relieving of honey-fried RADIX POLYGALAE eliminating phlegm and diminishing swelling is adjutant；Root of bidentate achyranthes invigorate blood circulation network, filling liver kidney, behavior guiding drug under priming；All medicines share, plays the work(of strengthening vital QI to eliminate pathogenic factors, clearing heat and promoting diuresis, swelling and pain relieving altogether, with strengthening vital QI to eliminate pathogenic factors, clearing heat and promoting diuresis, swelling and pain relieving effect, to treat both principal and secondary aspect of disease, safely and effectively pure Chinese medicinal preparation.
Description
Technical field
The present invention relates to a kind of herbal mixture, more particularly to a kind of compound traditional Chinese medicine composite for treating acute stage of gout and its
Using.
Background technology
Gout is the arthropathy caused by a kind of uric acid mineralization, caused by purine metabolic disturbance and/or underexcretion
Hyperuricemia it is directly related.Acute stage of gout is mainly shown as that burst joint and surrounding soft tissue are rubescent, generates heat, swelling is acute
Pain is main clinical manifestation.China's illness rate is about 0.34%~2.84%, is increased significantly than before.Acute stage of gout is often adopted
With Effects of Colchicine In Treating, due to there is more serious gastrointestinal side effect, clinical practice is restricted, therefore, find safely, effectively
The method for the treatment of acute stage of gout just expected by clinician.
According to the sings and symptoms of acute stage of gout, the category of traditional Chinese medical science ownership " hot numbness ".Its interpretation of the cause, onset and process of an illness be human righteousness not
The pathological products such as foot, spleen renal dysfunction, damp and hot phlegm-blood stasis gather in internal, channels and collaterals of being detained, multiple because of improper diet and overtiredness, damaged by excess of seven emotions, sense
By exopathogen, inside and outside conjunction is evil, and qi and blood stagnation is obstructed, and wet turbidity current notes joint, and it is gout to send out, and the symptoms such as red, swollen, hot, pain occurs.Therefore
Strengthening vital QI to eliminate pathogenic factors, clearing heat and promoting diuresis, swelling and pain relieving are the basic therapies of acute stage of gout.
In the prior art, Chinese patent database discloses various herbal mixtures for treating gouts (such as
CN201310737037.8、CN201410150392.X、CN201310723249.0、CN201310642949.7、
CN200510039040.8 etc.), the medicine disclosed in above-mentioned patent is the main principles of formulating prescriptions with clearing heat and promoting diuresis, swelling and pain relieving,
Even if taking into account righting, its effect is little；And in the market still not for the Chinese patent drug of acute stage of gout.
Accordingly, it would be desirable to a kind of present invention is directed to the deficiencies in the prior art and defect, there is provided one kind treats gout urgency
The herbal mixture of property phase, makes it have the effect of strengthening vital QI to eliminate pathogenic factors, clearing heat and promoting diuresis, swelling and pain relieving, to treat both principal and secondary aspect of disease, safely and effectively
Pure Chinese medicinal preparation.
The content of the invention
In view of this, it is an object of the invention to provide a kind of compound traditional Chinese medicine composite for treating acute stage of gout and its should
With, with strengthening vital QI to eliminate pathogenic factors, clearing heat and promoting diuresis, swelling and pain relieving effect, to treat both principal and secondary aspect of disease, safely and effectively pure Chinese medicinal preparation.
The compound traditional Chinese medicine composite for the treatment of acute stage of gout of the invention, composition material includes with the following group by weight
Point：
Radix Astragali 30-60 parts, honey-fried RADIX POLYGALAE 5-15 parts, stem of noble dendrobium 15-30, radix achyranthis bidentatae 10-20 parts, honeysuckle 5-15 parts, rhizoma atractylodis 5-
15 parts, golden cypress 5-15 parts of 10-30 parts of, Bi Collettii, smilax 10-30, corydalis tuber 10-30 parts；
Further, composition material includes following components by weight：
Radix Astragali 40-60 parts, honey-fried RADIX POLYGALAE 8-13 parts, stem of noble dendrobium 18-25, radix achyranthis bidentatae 13-17 parts, honeysuckle 8-13 parts, rhizoma atractylodis 8-
13 parts, golden cypress 8-13 parts of 18-25 parts of, Bi Collettii, smilax 20-30, corydalis tuber 15-25 parts；
Further, composition material includes following components by weight：
50 parts of the Radix Astragali, 10 parts of honey-fried RADIX POLYGALAE, the stem of noble dendrobium 20,15 parts of radix achyranthis bidentatae, 10 parts of honeysuckle, 10 parts of rhizoma atractylodis, 10 parts of golden cypress, Bi
22 parts of Collettii, smilax 25,20 parts of corydalis tuber；
Further, one or more Chinese medicine for improving or treating accompanying symptoms can be added；
Further, the preparation that the acceptable pharmaceutical carrier of medical science can be added to be made.
Invention additionally discloses a kind of compound traditional Chinese medicine composite for treating acute stage of gout for preparing treatment treatment pain
The application of the medicine of wind acute stage.
Beneficial effects of the present invention：The compound traditional Chinese medicine composite for the treatment of acute stage of gout of the invention, it is acute for gout
The basic pathogenesis of phase, takes into full account drug matching principle, and the Radix Astragali is reused in side, and building up healthful vital energy is dispelled with commanding the through disease institute of all medicines
Heresy is outgoing, and it is monarch drug in a prescription to exempt from numbness and remove stagnant；Stem of noble dendrobium slightly sweet flavor, property is trembled with fear partially, and nourishing Yin and promoting production of body fluid heat-clearing is with principal drug assistance；Smilax, golden cypress are cold in nature
To win heat, hardship is apt to remove the damp and hot of lower Jiao with eliminating dampness；Bi Collettii, rhizoma atractylodis invigorating the spleen to dry eliminating impediment, are altogether ministerial drug.Honeysuckle removing toxic substances disappears
Swollen, corydalis tuber blood stasis dispersing and deswelling, the common swelling and pain relieving of honey-fried RADIX POLYGALAE eliminating phlegm and diminishing swelling is adjutant.Root of bidentate achyranthes invigorate blood circulation network, filling liver kidney, priming
Lower behavior guiding drug.All medicines share, plays the work(of strengthening vital QI to eliminate pathogenic factors, clearing heat and promoting diuresis, swelling and pain relieving altogether.Clinically the present invention can substantially change
Kind patient with gout red, swollen, hot, pain symptoms, promote joint function recovery, with strengthening vital QI to eliminate pathogenic factors, clearing heat and promoting diuresis, swelling and pain relieving work
With to treat both principal and secondary aspect of disease, safely and effectively pure Chinese medicinal preparation.
The Radix Astragali：It is sweet, temperature, return lung, the spleen channel, invigorating qi for strengthening superficies, pus draining and toxin expelling, diuresis, myogenic.Taken off for treatment deficiency of vital energy weak, chronic diarrhea
The long disunion of anus, spontaneous perspiration, oedema, sub-official prolapses, chronic rephrilis protinuria, diabetes, the open sore part.
Polygala：It is warm in nature, it is bitter, pungent, with tranquilize the mind and promote the intelligence, eliminating the phlegm, detumescence function, for the insomnia that breakdown of the normal physiological coordination between the heart and the kidney causes
Dreaminess, forgetful palpitation with fear, wandering, expectoration is not well, sore swollen toxin, mastosis.
The stem of noble dendrobium：Property slightly sweet flavor it is micro- salty, tremble with fear, return stomach, kidney, lung channel, promote the production of body fluid beneficial stomach, clearing heat and nourishing yin.Consumption of body fluid caused by febrile disease is controlled, dry is tired of
Yearningly, abnormal heat after being ill, impairment of yin mesh is dark.
Radix achyranthis bidentatae：It is picric acid, flat, enter the heart, liver, the warp of large intestine three, it is longer than and tonifies the liver and kidney, strong waist and knee and promoting blood circulation, ensuring proper downward flow of the blood
Effect.Cold-dampness Impotence numbness, spasm of limbs are cured mainly, goinyalgia is unable to flex and stretch the extremities, by vim and vigour, fire of getting mildewed in warm conditions is rotten.
Honeysuckle：It is cold in nature, it is sweet, enter lung, the heart, stomach, with clearing heat and detoxicating effect, cure mainly warm disease heating, heat toxin blood
Dysentery, large carbuncle, pyogenic infections, scrofula, anal fistula.
Rhizoma atractylodis：Taste is pungent, hardship, warm in nature, returns spleen, stomach, Liver Channel, drying damp and strengthening spleen, expelling wind and clearing away cold, improving eyesight, for damp retention in middle-jiao, gastral cavity
Distention and fullness in the abdomen, diarrhea, oedema, tinea pedis impotence is knitted, and arthralgia pain due to rheumatism, anemofrigid cold, yctalopia, eyes dusk is puckery.
Golden cypress：Bitter, it is cold in nature, enter kidney, bladder warp.Heat-clearing and damp-drying drug, purging intense heat and detonicating, bring down a fever except steam.Hot dysentery is controlled, diarrhea disappears
Yearningly, jaundice, stranguria with turbid discharge, hemorrhoid are had blood in stool, also under leukorrhea, hectic fever due to yin labor heat, red eye, swell pain, aphthae, sore swollen toxin.
Bi Collettii：Hardship, puts down, and enters Liver Channel, stomach, bladder warp.Wind-dispelling, dampness removing.Control rheumatoid arthritis stubborn, lumbocrural pain, difficult urination,
Stranguria with turbid discharge, seminal emission, damp and hot sore.
Smilax：It is sweet light, to put down, liver, stomach, the spleen channel, dehumidifying, removing toxic substances is easing joint movement.For damp and hot stranguria with turbid discharge, under band, carbuncle swells,
Limbs contraction caused by scrofula, mange, syphilis and mercury poisoning, arthralgia and myalgia.
Corydalis tuber：Pungent, hardship, temperature, Return liver, the spleen channel, promoting blood circulation to remove blood stasis, regulating qi-flowing for relieving pain.Control all pains of trusted subordinate's waist and knee, irregular menstruation,
Hundred lumps in the abdomen, metrorrhagia, postpartum anemic fainting, lochiorrhagia, traumatic injury.
Specific embodiment
The compound traditional Chinese medicine composite of the treatment acute stage of gout of the present embodiment, composition material includes with the following group by weight
Point：
Radix Astragali 30-60 parts, honey-fried RADIX POLYGALAE 5-15 parts, stem of noble dendrobium 15-30, radix achyranthis bidentatae 10-20 parts, honeysuckle 5-15 parts, rhizoma atractylodis 5-
15 parts, golden cypress 5-15 parts of 10-30 parts of, Bi Collettii, smilax 10-30, corydalis tuber 10-30 parts；Reuse the Radix Astragali in side, building up healthful vital energy with
The through disease institute of all medicines is commanded, eliminating evil is gone out, and it is monarch drug in a prescription to exempt from numbness and remove stagnant；Stem of noble dendrobium slightly sweet flavor, property is trembled with fear partially, and nourishing Yin and promoting production of body fluid heat-clearing is helping monarch
Medicine；Smilax, golden cypress are cold in nature to win heat, and hardship is apt to remove the damp and hot of lower Jiao with eliminating dampness；Bi Collettii, rhizoma atractylodis invigorating the spleen to dry eliminating impediment, be altogether
Ministerial drug.Honeysuckle removing toxicity for detumescence, corydalis tuber blood stasis dispersing and deswelling, the common swelling and pain relieving of honey-fried RADIX POLYGALAE eliminating phlegm and diminishing swelling is adjutant.The root of bidentate achyranthes is invigorated blood circulation
Degrading the channel, filling liver kidney, behavior guiding drug under priming.All medicines share, plays the work(of strengthening vital QI to eliminate pathogenic factors, clearing heat and promoting diuresis, swelling and pain relieving altogether.
In the present embodiment, composition material includes following components by weight：
Radix Astragali 40-60 parts, honey-fried RADIX POLYGALAE 8-13 parts, stem of noble dendrobium 18-25, radix achyranthis bidentatae 13-17 parts, honeysuckle 8-13 parts, rhizoma atractylodis 8-
13 parts, golden cypress 8-13 parts of 18-25 parts of, Bi Collettii, smilax 20-30, corydalis tuber 15-25 parts；Dose is the mark efficacy of a drug, prescription
Although medicine composition is identical, the consumption of medicine is different, and its efficacy of a drug then has dividing for size.The mechanism of above-mentioned prescription is complicated
, compatibility produces synergy between each composition, directly affects clinical efficacy, and full presciption medicine amount is cleverly combined and produces unique treatment
Effect, it is just right, it is indispensable.The drug effect of the present embodiment is obvious.
In the present embodiment, composition material includes following components by weight：
50 parts of the Radix Astragali, 10 parts of honey-fried RADIX POLYGALAE, the stem of noble dendrobium 20,15 parts of radix achyranthis bidentatae, 10 parts of honeysuckle, 10 parts of rhizoma atractylodis, 10 parts of golden cypress, Bi
22 parts of Collettii, smilax 25,20 parts of corydalis tuber；The drug effect of the present embodiment is optimal.
In the present embodiment, one or more Chinese medicine for improving or treating accompanying symptoms can be added；Such as generate heat thirsty plus gypsum,
The wind-weed is with clearing heat, purging intense-heat；Swell and ache and substantially add Radix Isatidis, edible tulip etc. with swelling and pain relieving；It is vexed rather plus stir-baked FRUCTUS GARDENIAE, lily etc. with
Relieving restlessness that clears away heart-fire.In addition, can also add edible tulip, paniculate swallowwort can significantly lower serum uric acid level, improve blood viscosity, sargentodoxa cuneata,
Toddalia plays the effect for dispelling damp and hot, clearing heat and detoxicating dredging collateral swelling and pain relieving, and can both release Shi Re Bing Pian causes gout, and
Can elimination are damp and hot poison heresy streamer stop joint arthralgia and myalgia caused by gathering at the train of thought of joint, numb limb, redness and swelling of joints deformation etc.
Symptom, plays active numbness relieving and pain relieving effect, adds rhizoma alismatis, lycopodium calvatum to play diuresis jointly with all medicines of the invention, can rise
To effect of clearing damp diuresis, from traditional Chinese medical science angle say above medicine can by the Shi Re Bing Pian of gout patient's internal deposition and its
The Shi Re Bing Pian at the muscles and bones of joint is stagnated in the accumulation that his medicine is melted, and is excreted by urine under diuresis.
In the present embodiment, the preparation that the acceptable pharmaceutical carrier of medical science can be added to be made.Such as pass through pharmaceutical carrier system
Into forms such as granule, oral liquid, tablet, capsule, pills, can be realized using existing commercial process.
Invention additionally discloses a kind of compound traditional Chinese medicine composite for treating acute stage of gout for preparing treatment treatment pain
The application of the medicine of wind acute stage, can take the method for any prior art, and add any other composition, be treated for preparing
The medicine of gout.
Below by specific embodiment, the invention will be further elaborated.
Embodiment one
The compound traditional Chinese medicine composite of the treatment acute stage of gout of the present embodiment, composition material includes with the following group by weight
Point：
30 parts of the Radix Astragali, 5 parts of honey-fried RADIX POLYGALAE, 15 parts of the stem of noble dendrobium, 10 parts of radix achyranthis bidentatae, 5 parts of honeysuckle, 5 parts of rhizoma atractylodis, 5 parts of, Bi Collettiis of golden cypress
10 parts, 10 parts of smilax, 10 parts of corydalis tuber.
Embodiment two
The compound traditional Chinese medicine composite of the treatment acute stage of gout of the present embodiment, composition material includes with the following group by weight
Point：
The Radix Astragali 60, honey-fried RADIX POLYGALAE 15, the stem of noble dendrobium 20, radix achyranthis bidentatae 20, honeysuckle 10, rhizoma atractylodis 15, the, Bi Collettiis 30, smilax of golden cypress 15
30th, corydalis tuber 30.
Embodiment three
The compound traditional Chinese medicine composite of the treatment acute stage of gout of the present embodiment, composition material includes with the following group by weight
Point：
40 parts of the Radix Astragali, 8 parts of honey-fried RADIX POLYGALAE, the stem of noble dendrobium 18,13 parts of radix achyranthis bidentatae, 8 parts of honeysuckle, 8 parts of rhizoma atractylodis, 8 parts of, Bi Collettiis 18 of golden cypress
Part, smilax 20,15 parts of corydalis tuber.
Example IV
The compound traditional Chinese medicine composite of the treatment acute stage of gout of the present embodiment, composition material includes with the following group by weight
Point：
60 parts of the Radix Astragali, 13 parts of honey-fried RADIX POLYGALAE, the stem of noble dendrobium 25,17 parts of radix achyranthis bidentatae, 13 parts of honeysuckle, 13 parts of rhizoma atractylodis, 13 parts of golden cypress, Bi
25 parts of Collettii, smilax 30,25 parts of corydalis tuber.
Embodiment five
The compound traditional Chinese medicine composite of the treatment acute stage of gout of the present embodiment, composition material includes with the following group by weight
Point：
30 parts of the Radix Astragali, 13 parts of honey-fried RADIX POLYGALAE, the stem of noble dendrobium 15,13 parts of radix achyranthis bidentatae, 15 parts of honeysuckle, 13 parts of rhizoma atractylodis, 5 parts of golden cypress, Bi
25 parts of Collettii, smilax 30,15 parts of corydalis tuber.
Embodiment six
The compound traditional Chinese medicine composite of the treatment acute stage of gout of the present embodiment, composition material includes with the following group by weight
Point：
50 parts of the Radix Astragali, 10 parts of honey-fried RADIX POLYGALAE, the stem of noble dendrobium 20,15 parts of radix achyranthis bidentatae, 10 parts of honeysuckle, 10 parts of rhizoma atractylodis, 10 parts of golden cypress, Bi
22 parts of Collettii, smilax 25,20 parts of corydalis tuber.
Embodiment seven
The compound traditional Chinese medicine composite of the treatment acute stage of gout of the present embodiment, composition material includes with the following group by weight
Point：
60 parts of the Radix Astragali, 15 parts of honey-fried RADIX POLYGALAE, the stem of noble dendrobium 30,20 parts of radix achyranthis bidentatae, 15 parts of honeysuckle, 15 parts of rhizoma atractylodis, 15 parts of golden cypress, Bi
30 parts of Collettii, smilax 30,30 parts of corydalis tuber.
The following is Chinese medicine composition clinical research situation of the present invention, show work of the present invention in acute stage of gout treatment
With：
Ordinary circumstance
Clinically selection meets the patient 72 of acute stage of gout, 18~65 years old age, average 46.44 ± 12.22 years old, disease
Journey 0.5~3.5 day, average 1.88 ± 1.95 days.
Diagnostic criteria
With reference to American Rheumatism Association's standard in 1977.
Looked into synovial bursa liquid and see specific urate crystal：Or tophus is through chemical method or PLM, card
It is real to contain Monosodium urate crystallization：Or possess 6 persons in following clinical manifestation, laboratory examination and x-ray sign etc. 12：
1) case standard is included
Voluntarily as study subject；Age between 18~65 years old, after morbidity in 48 hours, meets acute stage of gout diagnosis
Standard person.
2) exclusion standard
1. chronic Diffuse Connective Tissue Disease.2. anti-trioxypurine medicine (such as other purine) or other Chinese medicine anti-trioxypurines are disabled<2
Week.3. pregnant, preparation gestation and women breast-feeding their children.4. hepatopathy active stage or abnormal liver function, kidney function damage；Merge intentionally, lung,
Central nervous system disease or malignant tumour；Mental disease；Blood routine：WBC or Hb or PLT is offline less than normal value, or has other
Disease in the blood system person；Or dysnoesia can not correctly describe itself sense receptor.5. there is active peptic ulcer within nearly 1 year.⑥
There is excessive drinking, take drugs or drug abuser.7. allergic constitution or to multi-medicament allergy.
Therapeutic scheme
Chinese medicine compound prescription of the present invention is given with being decocted in water for oral dose；During decoction, in the case where this Chinese medicine composition effect is not influenceed, can
According to the different Chinese medicines for adding one or more to be used to improving or treating accompanying symptoms of the state of an illness, generate heat thirsty plus gypsum, the wind-weed are with heat-clearing
Let out fire；Swell and ache and substantially add Radix Isatidis, edible tulip etc. with swelling and pain relieving；It is vexed rather not add stir-baked FRUCTUS GARDENIAE, lily etc. with relieving restlessness that clears away heart-fire.72
Example patient is randomly divided into 3 groups, every group 24, the treatment of embodiment one to three, the course for the treatment of 7 days is given respectively.
Observation index：
1) observation index：
Redness and swelling of joints heat pain, tcm symptom and inflammatory parameters change.
2) criterion of therapeutical effect：Reference《New Chinese medicine guideline of clinical investigations》The curative effect determinate standard of middle formulation.Clinic is slow
Solution：Symptom, sign disappear, and test in laboratory leading indicator (including erythrocyte sedimentation rate, c reactive protein) is recovered or close normal, total mark
Reduced before relatively treating>95%；It is effective：Symptom, sign disappear substantially, and laboratory examination leading indicator is obviously improved, total mark compared with
Reduced before treatment<95% but>70%；Effectively：Symptom, sign mitigate, and laboratory examination leading indicator makes moderate progress, total mark compared with
Reduced before treatment<70% but>30%；It is invalid：Symptom, sign and lab index are not improved, and total mark subtracts before relatively treating
It is few<30%.
3) safety detection：Blood, urine, feces routine and Liver and kidney function, each record 1 time before and after electrocardiogram treatment.
Result of study
The effective percentage 95.8% of clinical efficacy embodiment one, the aobvious rate 62.5% of control；The effective percentage 100% of embodiment two, the aobvious rate of control
83.3%；The effective percentage 95.8% of embodiment three, the aobvious rate 62.5% of control；Show that the embodiment of the present invention two is optimal.Concrete outcome is shown in
Table 1.
The clinical observation on the therapeutic effect of table 1. (example)
The comparing of the forward and backward either disease integration for the treatment of or TCM symptom score, through statistical analysis, P<0.05, have
Significant difference.Wherein the rubescent of joint, swelling, pain, heating improves especially pronounced, is specifically shown in Table 2.
The disease of table 2., syndrome score compare
(P ＜ 0.05) is decreased obviously through treating forward and backward erythrocyte sedimentation rate, c reactive protein, concrete outcome is shown in Table 3.
Inflammation index comparable situation before and after 3. two groups of treatments of table
Safety evaluation result：Treat the change that forward and backward every Safety Evaluation Index is showed no statistical significance.Control
Occur epigastric discomfort 1, fash 1, not specially treated spontaneous remission during treatment.
Result shows：Chinese medicine compound prescription of the present invention has obvious therapeutic action to acute stage of gout, and its side effect is slight, have compared with
Clinical generalization value high.
Medical record is illustrated
Example 1：Zhang, man, 63 years old.There is right instep and swells and ache 2 days without obvious inducement in patient, tactile scorching hot, red tongue with yellowish fur
It is greasy, veins is sliding.Previously there is gout medical history, have a blood test, routine urinalysis (-), erythrocyte sedimentation rate, c reactive protein are slightly raised, blood uric acid:578μmol/
L.Diagnosis：Acute stage of gout, Chinese medical discrimination：Damp-heat accumulation.The treatment of the embodiment of the present invention four is given, treatment is relieved for 3 days, 5
It is returned to normal, after give anti-trioxypurine treatment.
Example 2：Zhu, man 45 years old, goes to a doctor for red and swollen 1 day because of left foot Metatarsophalangeal joint, and patient's night yesterday pain is unexpected
Breaking-out, acutely unbearably, takes anti-inflammation analgesic curative effect unobvious certainly.Existing plantar toe is red and swollen substantially, dry, bitter taste, vexed not peaceful, the tip of the tongue
Red yellow tongue fur is thick, veins is sliding.Have a blood test uric acid:765 μm of ol/L, erythrocyte sedimentation rate:38mm/h, c reactive protein:28mg/L, blood, routine urinalysis (-).Examine
It is disconnected：Acute stage of gout, Chinese medical discrimination：Damp-heat accumulation.The treatment of the embodiment of the present invention five is given, treatment 6 days is complete incidence graph, check
Blood uric acid:565 μm of ol/L, erythrocyte sedimentation rate, c reactive protein (-).
Example 3：Wei, man 23 years old, gout recurrent exerbation half a year, goes to a doctor because aggravating 1 day.After patient's half a year cause food chafing dish
There is right sufficient Metatarsophalangeal joint red and swollen, gout is made a definite diagnosis after local hospital is improved and checked, because being busy with one's work, do not carry out specification and control
Treat, because unit is had a dinner party before 1 day, drink postemphasis and go to a doctor.Quarter examines：Red tongue with yellowish fur has crackle, thready rapid pulse.According to medical history, symptom
Sign, diagnoses gout, and dialectical damp-heat and impairment of yin type serious gives six treatment of the invention, treats 5 days symptom mitigations, consolidates recovery from illness in 2 days.
As can be seen here, present invention treatment gout curative effect affirmative, clinical practice safely and effectively, has solely for acute stage of gout
Special advantage.
Finally illustrate, the above embodiments are merely illustrative of the technical solutions of the present invention and it is unrestricted, although with reference to compared with
Good embodiment has been described in detail to the present invention, it will be understood by those within the art that, can be to skill of the invention
Art scheme is modified or equivalent, and without deviating from the objective and scope of technical solution of the present invention, it all should cover at this
In the middle of the right of invention.
Claims (6)
1. a kind of compound traditional Chinese medicine composite for treating acute stage of gout, it is characterised in that：Composition material by weight include with
Lower component：
Radix Astragali 30-60 parts, honey-fried RADIX POLYGALAE 5-15 parts, stem of noble dendrobium 15-30, radix achyranthis bidentatae 10-20 parts, honeysuckle 5-15 parts, rhizoma atractylodis 5-15 parts,
Golden cypress 5-15 parts of 10-30 parts of, Bi Collettii, smilax 10-30, corydalis tuber 10-30 parts.
2. it is according to claim 1 treatment acute stage of gout compound traditional Chinese medicine composite, it is characterised in that：Composition material
Include following components by weight：
Radix Astragali 40-60 parts, honey-fried RADIX POLYGALAE 8-13 parts, stem of noble dendrobium 18-25 parts, radix achyranthis bidentatae 13-17 parts, honeysuckle 8-13 parts, rhizoma atractylodis 8-13
Part, golden cypress 8-13 parts of 18-25 parts of, Bi Collettii, smilax 20-30, corydalis tuber 15-25 parts.
3. it is according to claim 2 treatment acute stage of gout compound traditional Chinese medicine composite, it is characterised in that：Composition material
Include following components by weight：
50 parts of the Radix Astragali, 10 parts of honey-fried RADIX POLYGALAE, the stem of noble dendrobium 20,15 parts of radix achyranthis bidentatae, 10 parts of honeysuckle, 10 parts of rhizoma atractylodis, 10 parts of, Bi Collettiis 22 of golden cypress
Part, smilax 25,20 parts of corydalis tuber.
4. it is according to claim 1 treatment acute stage of gout compound traditional Chinese medicine composite, it is characterised in that：One kind can be added
Or various Chinese medicines for improving or treating accompanying symptoms.
5. it is according to claim 1 treatment acute stage of gout compound traditional Chinese medicine composite, it is characterised in that：Medical science can be added
The preparation that acceptable pharmaceutical carrier is made.
6. the compound traditional Chinese medicine composite according to any described treatment acute stage of gout of claim 1-5 for preparing treatment
Treat the application of the medicine of acute stage of gout.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710022330.4A CN106729212B (en) | 2017-01-12 | 2017-01-12 | Compound traditional Chinese medicine composition for treating acute stage of gout and application thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710022330.4A CN106729212B (en) | 2017-01-12 | 2017-01-12 | Compound traditional Chinese medicine composition for treating acute stage of gout and application thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN106729212A true CN106729212A (en) | 2017-05-31 |
| CN106729212B CN106729212B (en) | 2021-01-26 |
Family
ID=58947933
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710022330.4A Active CN106729212B (en) | 2017-01-12 | 2017-01-12 | Compound traditional Chinese medicine composition for treating acute stage of gout and application thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106729212B (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110693936A (en) * | 2019-10-17 | 2020-01-17 | 上海长海医院 | Traditional Chinese medicine composition for reducing uric acid and preventing and treating hyperuricemia or gout and application thereof |
| CN111905053A (en) * | 2020-09-02 | 2020-11-10 | 许永雄 | Medicine for treating gout and preparation method thereof |
| CN112022966A (en) * | 2020-10-10 | 2020-12-04 | 中国药科大学 | Traditional Chinese medicine composition for preventing, relieving and/or treating hyperuricemia |
| CN113713060A (en) * | 2021-10-25 | 2021-11-30 | 陕西省中医医院 | Blood stasis removing and turbidity lowering prescription for treating gout |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102114204A (en) * | 2010-10-28 | 2011-07-06 | 孔祥军 | Traditional Chinese medicine formula for treating gout |
| CN103705809A (en) * | 2013-12-23 | 2014-04-09 | 邵正荣 | Traditional Chinese medicine for curing gout |
-
2017
- 2017-01-12 CN CN201710022330.4A patent/CN106729212B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102114204A (en) * | 2010-10-28 | 2011-07-06 | 孔祥军 | Traditional Chinese medicine formula for treating gout |
| CN103705809A (en) * | 2013-12-23 | 2014-04-09 | 邵正荣 | Traditional Chinese medicine for curing gout |
Non-Patent Citations (1)
| Title |
|---|
| 丁建华: "清热化瘀泄浊通络法治疗急性痛风性关节炎54例", 《吉林中医药》 * |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN110693936A (en) * | 2019-10-17 | 2020-01-17 | 上海长海医院 | Traditional Chinese medicine composition for reducing uric acid and preventing and treating hyperuricemia or gout and application thereof |
| CN111905053A (en) * | 2020-09-02 | 2020-11-10 | 许永雄 | Medicine for treating gout and preparation method thereof |
| CN112022966A (en) * | 2020-10-10 | 2020-12-04 | 中国药科大学 | Traditional Chinese medicine composition for preventing, relieving and/or treating hyperuricemia |
| CN112022966B (en) * | 2020-10-10 | 2022-03-08 | 中国药科大学 | Traditional Chinese medicine composition for preventing, relieving and/or treating hyperuricemia |
| CN113713060A (en) * | 2021-10-25 | 2021-11-30 | 陕西省中医医院 | Blood stasis removing and turbidity lowering prescription for treating gout |
| CN113713060B (en) * | 2021-10-25 | 2022-07-05 | 陕西省中医医院 | Blood stasis removing and turbidity lowering prescription for treating gout |
Also Published As
| Publication number | Publication date |
|---|---|
| CN106729212B (en) | 2021-01-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102441081A (en) | Medicament for treating gout and its preparation method | |
| CN106729212A (en) | Treat compound traditional Chinese medicine composite and its application of acute stage of gout | |
| CN108704108A (en) | A kind of medicine pill for treating gout | |
| CN103083592B (en) | Traditional Chinese medicine for treating gouty arthritis | |
| CN101559203A (en) | Chinese medicament preparation for treating angina pectoris | |
| CN103446575B (en) | Medicine for treating gout | |
| CN103285183A (en) | Traditional Chinese medicine for treatment of uremia | |
| CN106620604A (en) | Navel moxibustion traditional Chinese medicine composition for treating chronic diarrhea as well as preparation method and application thereof | |
| CN104306948A (en) | Medicament composition for treating gouty arthritis | |
| CN103768214B (en) | A kind of Chinese medicine composition for the treatment of kidney yang deficiency syndrome rhinitis | |
| CN102793903B (en) | Preparation method of Chinese medicament for treating kidney-yang deficiency type acute glomerulonephritis | |
| CN102793866B (en) | Preparation method for traditional Chinese medicine used for treatment of feet oedema type acute glomerulonephritis | |
| CN106309989A (en) | Drug for treating uremia and complication thereof | |
| CN106138919A (en) | A kind of Chinese medicine composition treating gastric cancer | |
| CN104689253A (en) | Traditional Chinese medicine composition for treating gallbladder removal syndromes | |
| CN106266970B (en) | A kind of Chinese medicine composition treated production and cause endometritis | |
| CN106729213A (en) | Treat herbal mixture and its application of rheumatoid arthritis acute stage | |
| CN102805853B (en) | Preparation method of traditional Chinese medicine for treating proteinuria type acute glomerulonephritis | |
| CN104027751A (en) | Traditional Chinese medicine preparation for treating chronic cholecystitis | |
| CN102188669B (en) | Medicament for treating cold-dampness obstruction syndrome and preparation method thereof | |
| CN102813896B (en) | Preparation method of traditional Chinese medicine for treating cold sensitivity-type acute glomerulonephritis | |
| CN113332398A (en) | Miao medicine composition for treating acute attack of gouty arthritis | |
| CN114588241A (en) | Traditional Chinese medicine composition for treating gout and hyperuricemia | |
| CN109224013A (en) | The Chinese medicinal formulae for treating rheumatoid arthritis active stage | |
| CN108853281A (en) | A kind of clearing damp removing toxic substances enema fluid and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |